Substantia nigra
A brain structure involved in movement and reward
The substantia nigra is a critical structure located in the midbrain that plays a significant role in movement and reward. It is part of the basal ganglia, a group of nuclei in the brain associated with a variety of functions including motor control, emotions, and cognitive functions.
Anatomy
The substantia nigra is divided into two main parts: the pars compacta and the pars reticulata.
Pars Compacta
The pars compacta is densely packed with dopaminergic neurons, which produce the neurotransmitter dopamine. These neurons project to various parts of the brain, including the striatum, and are crucial for the regulation of movement. The loss of dopaminergic neurons in the pars compacta is a hallmark of Parkinson's disease, leading to the characteristic motor symptoms of the disorder.
Pars Reticulata
The pars reticulata, on the other hand, contains GABAergic neurons and is involved in the regulation of eye movements and motor planning. It acts as an output nucleus of the basal ganglia, sending inhibitory signals to the thalamus and superior colliculus.
Function
The substantia nigra is primarily involved in the modulation of motor activity. It plays a key role in the initiation and smooth execution of movements. The dopaminergic neurons of the pars compacta modulate the activity of the striatum, influencing the direct and indirect pathways of the basal ganglia circuitry.
Role in Reward
In addition to its role in movement, the substantia nigra is also involved in the brain's reward system. Dopamine release from the substantia nigra is associated with the reinforcement of rewarding behaviors, influencing motivation and learning.
Clinical Significance
Parkinson's Disease
The degeneration of dopaminergic neurons in the substantia nigra pars compacta is a primary pathological feature of Parkinson's disease. This leads to a decrease in dopamine levels in the striatum, resulting in the motor symptoms such as tremors, rigidity, and bradykinesia.
Other Disorders
The substantia nigra is also implicated in other neurological disorders such as Huntington's disease, schizophrenia, and drug addiction. Alterations in dopamine signaling in the substantia nigra can affect mood, cognition, and behavior.
Research
Ongoing research is focused on understanding the precise mechanisms of neuron degeneration in the substantia nigra and developing therapeutic strategies to protect or restore dopaminergic function. Techniques such as deep brain stimulation and stem cell therapy are being explored as potential treatments for disorders involving the substantia nigra.
Related pages
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers a medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Budget GLP1 shots (generic and brand names) such as
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Budget GLP1 weight loss injections such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our:
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
GLP1 weight loss doctor NYC, Zepbound NYC, Budget GLP1 weight loss injections, Philadelphia medical weight loss, Wegovy NYC, Brooklyn weight loss, Wegovy NYC, Budget GLP1 shots NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian